Piper Sandler lowers Blackstone stock price target to $168 on 4Q outlook

Published 24/10/2025, 14:28
Piper Sandler lowers Blackstone stock price target to $168 on 4Q outlook

Investing.com - Piper Sandler has reduced its price target on Blackstone Group (NYSE:BX) stock to $168.00 from $173.00 while maintaining a Neutral rating, citing concerns about fourth-quarter expectations. The investment management giant, currently valued at $190.5 billion, trades at a relatively high P/E ratio of 46.5x, according to InvestingPro data.

The research firm noted that Blackstone shares fell 4% despite posting solid third-quarter results, attributing the weakness to projected softer fee-related earnings margins and a deceleration in management fees expected in the fourth quarter of 2025. Despite market volatility, Blackstone has demonstrated strong performance with 37% revenue growth over the last twelve months and maintains a GOOD financial health rating on InvestingPro.

Performance revenues drove Blackstone’s quarterly earnings beat, with management indicating that 2026 could be its largest year in issuance if the anticipated IPO pipeline materializes, according to Piper Sandler’s analysis.

The firm highlighted comments from Blackstone CEO Steve Schwarzman addressing industry concerns, who stated that recent defaults at banks have been "erroneously linked" to private credit issues.

Piper Sandler raised its 2025 and 2026 earnings estimates to $5.28 and $6.45 respectively, up from previous projections of $4.99 and $6.42, while introducing a 2027 estimate of $7.72, but lowered its price target multiple to approximately 26x from 27x due to peer multiple contraction.

In other recent news, Blackstone Group reported third-quarter earnings for 2025, with distributable earnings of $1.52 per share, significantly exceeding analysts’ estimates of $1.20 and the consensus forecast of $1.22. Despite this earnings beat, the company reported revenue of $3.09 billion, falling short of the expected $3.2 billion. Blackstone is also reportedly among a group of private equity firms considering offers for Optum’s UK unit, owned by UnitedHealth Group. In response to the earnings report, Citizens maintained its Market Outperform rating for Blackstone, reiterating a price target of $195.00. Meanwhile, Evercore ISI adjusted its price target for Blackstone to $175.00 from $180.00, while still maintaining an Outperform rating. These developments highlight the mixed reactions from analysts following the company’s earnings performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.